全文获取类型
收费全文 | 8504篇 |
免费 | 662篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 263篇 |
妇产科学 | 178篇 |
基础医学 | 1134篇 |
口腔科学 | 108篇 |
临床医学 | 1552篇 |
内科学 | 1447篇 |
皮肤病学 | 88篇 |
神经病学 | 800篇 |
特种医学 | 162篇 |
外科学 | 629篇 |
综合类 | 111篇 |
一般理论 | 10篇 |
预防医学 | 1411篇 |
眼科学 | 112篇 |
药学 | 531篇 |
中国医学 | 2篇 |
肿瘤学 | 572篇 |
出版年
2023年 | 95篇 |
2022年 | 84篇 |
2021年 | 157篇 |
2020年 | 135篇 |
2019年 | 219篇 |
2018年 | 222篇 |
2017年 | 198篇 |
2016年 | 186篇 |
2015年 | 234篇 |
2014年 | 315篇 |
2013年 | 433篇 |
2012年 | 679篇 |
2011年 | 671篇 |
2010年 | 332篇 |
2009年 | 301篇 |
2008年 | 548篇 |
2007年 | 597篇 |
2006年 | 565篇 |
2005年 | 593篇 |
2004年 | 503篇 |
2003年 | 548篇 |
2002年 | 485篇 |
2001年 | 60篇 |
2000年 | 44篇 |
1999年 | 73篇 |
1998年 | 109篇 |
1997年 | 74篇 |
1996年 | 54篇 |
1995年 | 54篇 |
1994年 | 58篇 |
1993年 | 64篇 |
1992年 | 33篇 |
1991年 | 33篇 |
1990年 | 24篇 |
1989年 | 27篇 |
1988年 | 33篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 38篇 |
1983年 | 30篇 |
1982年 | 26篇 |
1981年 | 31篇 |
1980年 | 27篇 |
1979年 | 11篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1973年 | 10篇 |
排序方式: 共有9185条查询结果,搜索用时 15 毫秒
91.
Sally Betz Corradin Jacques Mauël Susanne Denis Donini Emilia Quattrocchi Paola Ricciardi-Castagnoli 《Glia》1993,7(3):255-262
Nitric oxide (NO) is a short-lived diffusable molecule now believed to participate in multiple physiologic functions in the CNS including neurotransmission and the maintenance of vascular tone. Previously, we reported that cell lines obtained by retroviral immortalization of tissue macrophages (M?;) could be induced to synthesize nitrite (NO), a stable end product of the NO synthetic pathway. We have further characterized the induction and activity of this pathway in a panel of seven microglial clones derived from primary embryonic mouse brain cultures. Like M?;, these clones were found to release high levels of NO-2 in response to recombinant interferon-γ (rIFN-γ) as a priming signal together with either bacterial lipopolysaccharide (LPS) or exogenous recombinant tumor necrosis factor-α (rTNF-α). As previously demonstrated for M?;, phagocytosis of zymosan particles during induction of enzyme activity enhanced subsequent NO production, which is of interest in light of the postulated phagocytic role of microglia within the CNS. Biochemical characterization of enzyme activity in intact microglial clones and in isolated cytosolic fractions indicates that the microglial NO synthase present in these murine cell clones represents the M?;-like isotype. These findings suggest that microglial cells could represent a major source of NO within the CNS. 相似文献
92.
Kirsten J. Dickers Sally M. Bradberry Paul Rice Gareth D. Griffiths J. Allister Vale 《Adverse drug reactions and toxicological reviews》2003,22(3):137-142
Abrin is a toxic protein obtained from the seeds of Abrus precatorius (jequirity bean), which is similar in structure and properties to ricin. Abrin is highly toxic, with an estimated human fatal dose of 0.1–1 µg/kg, and has caused death after accidental and intentional poisoning. Abrin can be extracted from jequirity beans using a relatively simple and cheap procedure. This satisfies one criterion of a potential chemical warfare agent, although the lack of large scale production of jequirity seeds means that quantity is unavailable for ready mass production of abrin for weapons. This contrasts with the huge cultivation of Ricinus seeds for castor oil production. At the cellular level, abrin inhibits protein synthesis, thereby causing cell death. Many of the features observed in abrin poisoning can be explained by abrin-induced endothelial cell damage, which causes an increase in capillary permeability with consequent fluid and protein leakage and tissue oedema (the so-called vascular leak syndrome). Most reported cases of human poisoning involve the ingestion of jequirity beans, which predominantly cause gastrointestinal toxicity. Management is symptomatic and supportive. Experimental studies have shown that vaccination with abrin toxoid may offer some protection against a subsequent abrin challenge, although such an approach is unlikely to be of benefit in a civilian population that in all probability would be unprotected. 相似文献
93.
Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. 总被引:3,自引:0,他引:3
Sally Baron-Hay Frances Boyle Alan Ferrier Carolyn Scott 《Clinical cancer research》2004,10(5):1796-1806
PURPOSE: The purpose of this research was to examine the diagnostic and prognostic significance of elevated serum insulin-like growth factor binding protein (IGFBP)-2 levels in women with ovarian cancer from diagnosis through treatment to relapse or remission. EXPERIMENTAL DESIGN: Serum collected pre- and postoperatively in women newly diagnosed with ovarian cancer, during adjuvant chemotherapy cycles, at 6 months follow-up and at relapse was analyzed for IGFBP-2. Control serum was from women undergoing pelvic or abdominal surgery for benign ovarian disease or nonovarian pathology. RESULTS: IGFBP-2 at diagnosis was significantly elevated (P < 0.0001) in women with ovarian cancer (887 +/- 62 ng/ml) compared with benign controls (337 +/- 25 ng/ml), and women undergoing nonovarian surgery (439 +/- 49 ng/ml) and correlated positively with tumor stage and cellular differentiation but not with CA125. Unexpectedly, IGFBP-2 levels increased additionally 1-week postoperatively in ovarian cancer patients (1581 +/- 90 ng/ml; P = 0.0027) as well as controls (977 +/- 95 ng/ml; P < 0.0001) and was higher in women who had suboptimal debulking compared with optimal debulking of their tumor. IGFBP-2 levels returned to normal in women without evidence of progressive disease, but remained significantly elevated in women who later relapsed. Patients with IGFBP-2 levels in the highest tertile at diagnosis had a significantly shorter progression-free interval and overall survival. CONCLUSION: In ovarian cancer IGFBP-2 is elevated at diagnosis, and corresponds to stage and histology with patients in the highest tertile of IGFBP-2 more likely to relapse and have a poorer outlook. Identification of these patients at diagnosis may allow more individualized, aggressive adjuvant treatment and follow-up, and IGFBP-2 may therefore be an important additional prognostic marker in this disease. 相似文献
94.
Judith McFarlane RN DrPH FAAN Barbara Parker RN PhD FAAN Karen Soeken PhD Connie Silva RN PhD Sally Reel RN PhD 《Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG》1998,27(1):64-69
Objective: To evaluate an intervention protocol, administered during pregnancy, for increasing safety-seeking behaviors of abused women.
Design: Prospective, ethnically stratified cohort analysis.
Setting: Public prenatal clinics.
Participants: Pregnant women reporting physical or sexual abuse in the year before or during the present pregnancy. One hundred thirty-two women met study criteria, received the intervention, and were followed for 1 year after the completion of the pregnancy.
Intervention: Three education, advocacy, and community referral sessions that included information on safety behaviors.
Main outcome Measure: Adoption of safety behaviors by abused women. Safety behaviors were measured before the intervention, twice during pregnancy, and at 2, 6, and 12 months after completion of the pregnancy.
Results: Repeated measures analysis of variance showed a significant increase in adoption of each safety behavior (p < .0001), with most behaviors showing a significant increase after the first intervention session.
Conclusions: Pregnant women who were abused and were offered an intervention protocol report a significant increase in safety behavior adoption during and after pregnancy. Abuse during pregnancy is common. Identification of abuse and immediate clinical intervention that includes information about safety behaviors can result in safety behavior adoption that may prevent future abuse and increase the safety and well-being of women and infants. 相似文献
Design: Prospective, ethnically stratified cohort analysis.
Setting: Public prenatal clinics.
Participants: Pregnant women reporting physical or sexual abuse in the year before or during the present pregnancy. One hundred thirty-two women met study criteria, received the intervention, and were followed for 1 year after the completion of the pregnancy.
Intervention: Three education, advocacy, and community referral sessions that included information on safety behaviors.
Main outcome Measure: Adoption of safety behaviors by abused women. Safety behaviors were measured before the intervention, twice during pregnancy, and at 2, 6, and 12 months after completion of the pregnancy.
Results: Repeated measures analysis of variance showed a significant increase in adoption of each safety behavior (p < .0001), with most behaviors showing a significant increase after the first intervention session.
Conclusions: Pregnant women who were abused and were offered an intervention protocol report a significant increase in safety behavior adoption during and after pregnancy. Abuse during pregnancy is common. Identification of abuse and immediate clinical intervention that includes information about safety behaviors can result in safety behavior adoption that may prevent future abuse and increase the safety and well-being of women and infants. 相似文献
95.
Rosie Ashbolt Jenny Barralet Robert Bell Dennis Bittisnich Andrew Black Barry Combs Christine Carson Scott Crerar Craig Dalton Joy Gregory Michelle Harlock Gillian Hall Geoff Hogg Martyn Kirk Karin Lalor Tony Merritt Sally Munnoch Jennie Musto Lillian Mwanri Leonie Neville Chris Oxenford Rhonda Owen Jane Raupach Cameron Sault Russell Stafford Barbara Telfer Hassan Vally Kefle Yohannes 《Communicable diseases intelligence》2005,29(1):85-88
96.
97.
Letter to the Editor
Letter to the Editor 相似文献98.
99.
100.
Theresa H M Keegan Sally L Glaser Christina A Clarke Margaret L Gulley Fiona E Craig Joseph A Digiuseppe Ronald F Dorfman Risa B Mann Richard F Ambinder 《Journal of clinical oncology》2005,23(30):7604-7613
PURPOSE: Epstein-Barr virus (EBV) in Hodgkin's lymphoma (HL) cells has been considered as a prognostic marker for this heterogeneous disease, but studies have yielded mixed findings, likely because of selected patient series and failure to acknowledge an effect of age on outcome. This study assessed survival after HL in a population-based cohort large enough to examine the joint effects of EBV with other factors including age, sex, and histologic subtype. PATIENTS AND METHODS: Included were 922 patients with classical HL diagnosed between mid-1988 and 1997 in the Greater San Francisco Bay Area, with archived biopsy specimens assayed for EBV with immunohistochemistry and in situ hybridization. Vital status was followed through December 30, 2003 (median follow-up time, 97 months). Overall and disease-specific survival were analyzed with the Kaplan-Meier method and Cox proportional hazards regression models. RESULTS: In children less than 15 years old, EBV presence was suggestively associated (P = .07) with favorable survival. In adults aged 15 to 44 years, EBV did not affect HL outcome, although a protective effect was suggested. In older adults (45 to 96 years), EBV presence nearly doubled the risk of overall and HL-specific mortality but only for patients with nodular sclerosis (NS) histologic subtype (hazard ratio for death = 2.5; 95% CI, 1.5 to 4.3). CONCLUSION: In HL, EBV tumor cell presence is associated with better survival in young patients and poorer survival in older patients with NS, independent of other factors. Variation in outcome by age and histology could indicate biologically distinct disease entities. Evidence that EBV is a meaningful prognostic marker may have therapeutic relevance. 相似文献